Twitter Logo Youtube Circle Icon LinkedIn Icon

Switzerland > Healthcare and life sciences > Law firm and leading lawyer rankings


Index of tables

  1. Healthcare and life sciences
  2. Leading individuals

Leading individuals

  1. 1

Who Represents Who

Find out which law firms are representing which Healthcare and life sciences clients in Switzerland using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


Bär & Karrer AG is ‘an excellent choice’ for health care providers as well as life sciences companies. It covers regulatory work as well as drug marketing and IP matters. Regulatory expert Markus Schott ‘possesses excellent analytic abilities’ and continues to assist Novartis with drug price-setting proceedings. Pharma patent expert Markus Wang successfully represented Spirig HealthCare in a patent dispute with Bayer regarding the launch of a generic contraceptive.

For some, Vischer is ‘considered the best in Switzerland’ for life sciences regulatory matters, including market authorisation, drug reimbursement pricing, and compliance reviews. The ‘very skilled and knowledgeableStefan Kohler is recommended for regulatory and patent matters, and Matthias Staehelin stands out for his corporate and commercial work for biotech companies. Clients include AC Immune, Astra Zeneca, Biogen, CRISPR Therapeutics, Kuros Biosciences and Med Cell Europe.

Homburger combines a leading life sciences transactions practice, led by Dieter Gericke, and an excellent pharma patent team, led by Georg Rauber. It advised Kuros Biosurgery on its merger with Cytos Biotechnology. Other clients include AbbVie, Baxter, Eli Lilly, GE Healthcare, and Sanofi-Aventis.

Kellerhals Carrard’s ‘excellent’ practice is recommended for regulatory work and product liability matters. It successfully represented health insurer KPT in a reimbursement dispute with a hospital group. Other clients include Bayer and Roche Pharma. Thomas Eichenberger has ‘a profound understanding of the healthcare industry’.

At Lenz & Staehelin, Thierry Calame provides ‘thoughtful and practical advice’ on pharma patent issues and also has expertise in drug advertising law, while Stephan Erni is noted for his ‘efficient and hands-on approach’ to commercial and corporate matters concerning the life sciences industry. Clients include Pfizer and MSD.

Meyerlustenberger Lachenal’s ‘excellent’ team is particularly recommended for patent disputes in the life sciences sector and also has experience with regulatory matters. Its clients include AstraZeneca, Bayer and H. Lundbeck. Practice head Simon Holzer ‘has expert knowledge in patents and life sciences’.

Standout work for Pestalozzi’s ‘very good’ team includes defending Zimmer against product liability claims regarding metal hip implants, advising Johnson & Johnson on apps that collect patient data, and assisting Astellas Pharma with compliance matters. Lorenza Ferrari Hofer and Christian Roos are recommended.

At Schellenberg Wittmer Ltd, the team handles patent and licensing disputes in the life sciences sector. Philippe Ducor left the practice to establish Ducor Law / Health & Technology in September 2016. Andrea Mondini joined TIMES Attorneys in October 2017.

Walder Wyss Ltd advised Molecular Health on market entry in Switzerland, assisted Teva with a complaint about marketing activities by a competitor, and continues to represent Pfizer in a price-setting dispute. Andreas Wildi and Alexander Gutmans are recommended.

At Wenger & Vieli, practice head Frank Scherrer is noted for his regulatory matters expertise in the life sciences sector. Recent work includes representing several pharmaceutical companies in appeals against price decrease decisions and assisting a client with re-assessment proceedings concerning Swissmedic market authorisation conditions.

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

GC Powerlist -

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

GC Powerlist -

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • 17 February 2017: Auris Medical's Public Equity Offering

    Auris Medical Holding AG (NASDAQ: EARS) issued and priced its public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share.  The common shares and warrants are being sold in units comprised of one common share and one warrant at the public offering price of USD 1.00 per unit. The warrants will be immediately exercisable at a price of USD 1.20 per common share and are exercisable for five years. In connection with the offering, the Company has granted the underwriter a 30-day option to purchase up to 1,500,000 additional common shares and/or 1,500,000 additional warrants at the public offering price less underwriting discounts. The offering is expected to close on or about February 21, 2017, subject to customary closing conditions. Roth Capital Partners is acting as sole book-running manager in the offering. Maxim Group LLC is acting as a financial advisor in the offering.
  • 16 February 2017: Credit Suisse successfully launched its new subsidiary Credit Suisse (Switzerland)

    Credit Suisse (Switzerland) Ltd. was incorporated with the purpose to be organized as a Swiss bank. It is a wholly owned subsidiary of Credit Suisse AG. The transfer of assets and liabilities according to Swiss merger law became effective on 20 November 2016. The transfer was aimed to evolve the legal entity structure of the Credit Suisse Group to meet regulatory requirements for systematically important banks.
  • 14 February 2017: BASF acquires Rolic Group

    BASF acquires Rolic, a Swiss based group offering innovative and forward-thinking solutions, particularly in the display and security industries as well as the optical film business.
  • 15 February 2017: gategroup CHF 300 mio. bond issuance

    gategroup successfully raised CHF 300 million through the issuance of a fixed rate 5-year senior bond with a final maturity on February 28, 2022. The bond with a coupon of 3% p.a. has been issued by gategroup Finance (Luxembourg) S.A. and is guaranteed by its parent company gategroup Holding AG. gategroup will apply for the listing of the new bond on the SIX Swiss Exchange.
  • 17 February 2017: RWS acquires LUZ, Inc.

    RWS Holdings plc, a world leading provider of intellectual property support services (patent translations, international patent filing solutions and searches), commercial translations and linguistic validation, has completed the acquisition of 100% of LUZ, Inc., a market leading Life Sciences language services provider based in San Francisco, for a cash consideration of USD82.5m.
  • 17 February 2017: Cembra Money Bank acquires invoice financing provider SWISSBILLING SA

    Cembra Money Bank has reached an agreement to acquire 100% of the shares of SWISSBILLING. The transaction is expected to close within the first quarter of 2017. The transaction consideration was below CHF 10 million and is expected to have a negative impact of 0.1% on the Group’s CET1 ratio as at closing.
  • 7 February 2017: TPF closes private offering and bank financing

    Transports publics fribourgeois Trafic (TPF TRAFIC) SA closed the financing of its maintenance and exploitation centre in the canton of Fribourg. The financing was partly made through a CHF 40 mio. private placement, a CHF 32 mio. secured bank loan and a CHF 55 mio. unsecured bank loan.
  • 3 February 2017: Migros acquires Tipesca

    The Migros Group, through Mérat & Cie. SA, has acquired Tipesca SA, a company incorporated in the canton of Tessin. Tipesca offers a wide range of fish products.
  • 24 January 2017: Sharp Corporation and Skytec Group Limited enter into strategic business alliance

    Japan-based Sharp Corporation, part of Taiwan’s Foxconn Group, enters into a strategic business alliance with Skytec Group Limited (“Skytec”) regarding the manufacture and sale of Sharp branded products and services in Europe. For that purpose, Sharp acquires a majority stake of 56.7% in the newly incorporated joint venture Skytec UMC Ltd.
  • 25 January 2017: Zug Estates CHF 100 mio. Bond

    Zug Estates Holding AG (SIX: ZUGN) has successfully issued its first CHF 100 mio. fixed-interest bond with a 0.7% coupon and a 5-year maturity.

Press Releases in Switzerland

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to
  • Bär & Karrer Welcomes New Tax Counsel

    Bär & Karrer is pleased to announce Prof. Dr. Andrea Opel as a new counsel to the firm. She joined the tax team in Zurich on 1 March 2018.
  • Bär & Karrer Advised Orior on the Placement of Shares by Way of an Accelerated Bookbuilding

    Orior AG successfully placed 592,499 new shares by way of an accelerated bookbuilding in a private placement with institutional investors. The placed shares are sourced from the company's existing authorized share capital and the pre-emptive rights of the existing shareholders have been excluded.
  • Bär & Karrer Advised HQLAx on the first Live Securities Lending Transaction Using R3's Corda Blockc

    On 1 March 2018, financial technology innovator HQLAx together with Credit Suisse and ING completed the first live securities lending transaction using R3's Corda blockchain platform. The transaction included a basket swap between Credit Suisse and ING of value EUR 25 million using the HQLAx Corda-based collateral lending application. During the transaction, Credit Suisse and ING transferred legal ownership of Dutch and German government securities on the platform using HQLAx Digital Collateral Records (DCRs) while the underlying securities remained static.
  • Bär & Karrer Advises Novartis on the Placement of EUR 2,250,000,000 Guaranteed Notes

    Novartis Finance S.A. completed the placement of EUR 750,000,000 Guaranteed Notes due 2023, EUR 750,000,000 Guaranteed Notes due 2030 and EUR 750,000,000 Guaranteed Notes due 2038. The 2023 Notes were issued at 99.655% of their principal amount with an interest of 0.500% and will mature on 14 August 2023 at their nominal value. The 2030 Notes were issued at 99.957% of their principal amount with an interest of 1.375% and will mature on 14 August 2030. The 2038 Notes were issued at 99.217% of their principal amount with an interest of 1.700% and will mature on 14 August 2038. The Notes are guaranteed by Novartis AG. They have been provisionally admitted to trading at the SIX Swiss Exchange and are expected to be listed there as well.
  • Bär & Karrer Advises EGSB on the Purchase of a Majority Stake in Bauwerk Boen

    EGS Beteiligungen AG (EGSB) has acquired all shares in Bauwerk Boen AG held by ZM Opportunity II L.P. (a fund advised by Patrimonium Private Equity) and is thus majority shareholder of the company. The Bauwerk Boen Group is a leading manufacturer of premium parquet flooring.
  • Promotions at Walder Wyss

    We are pleased to announce that our employees  Alexandre Both ,  Michael Cartier ,  Michael Feit ,  Hubertus Hillerström  and  Olivier Sigg , who have been with us for many years, have been appointed as partners in our firm, effective from 1st of January, 2018.
  • New counsel at Walder Wyss

    We are pleased to announce that a new counsel,  Christian Eichenberger , joined our firm as of 1st of January, 2018.
  • DPE acquires AWK Group

    Deutsche Private Equity (DPE) acquires majority interest in AWK Group, one of the largest independent Swiss consulting companies for information technology and digitalization. 
  • Metall Zug (SIX: METN) acquires majority holding in Haag-Streit Holding AG

    The Metall Zug Group has signed an agreement to acquire 70% of Haag-Streit Holding AG, based in Köniz, Switzerland. The transaction is expected to be consummated during the first quarter of 2018. 
  • Tamedia Announces Public Tender Offer for Goldbach Group

    Tamedia AG announces an all cash public tender offer for all publicly held shares of Goldbach Group AG listed on the SIX Swiss Exchange. Tamedia offers CHF 35.50 per share of Goldbach Group, representing a transaction amount of around CHF 216 million. The board of directors of Goldbach Group recommends to its shareholders to accept the offer.